Decreased drug absorption in a patient with Behcet's syndrome

7Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Observing a lack of response to orally administered drugs in a patient with Behcet's disease, we studied the absorption of amitriptyline, diazepam, carbamazepine, phenytoin, and acetaminophen in this patient after single and (or) multiple dose administrations. The relative oral/intramuscular bioavailability of amitriptyline was only 13%, and the steady-state concentrations of this drug on four consecutive days were acutely subtherapeutic (i.e., 3.6, 3.7, 3.9, and 3.7 μg/L). The concentrations of diazepam, phenytoin, and acetaminophen in plasma were nonmeasurable. Examination of the gastrointestinal tract by endoscopy and by light and electronic microscopy of a biopsy section revealed inflammatory and vascular changes in the duodenum. In the absence of clinical evidence for malabsorption syndrome, we believe that the decreased drug absorption observed in this patient was caused by inflammatory changes associated with Behcet's syndrome.

Cite

CITATION STYLE

APA

Chaleby, K., El-Yazigi, A., & Atiyeh, M. (1987). Decreased drug absorption in a patient with Behcet’s syndrome. Clinical Chemistry, 33(9), 1679–1681. https://doi.org/10.1093/clinchem/33.9.1679

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free